InvestorsHub Logo
Followers 53
Posts 9894
Boards Moderated 1
Alias Born 10/06/2005

Re: thumper1 post# 181

Friday, 09/13/2019 4:41:31 PM

Friday, September 13, 2019 4:41:31 PM

Post# of 1668
I didn't study the details but think this is significent
"Profound is also commercializing Sonalleve(R), an innovative therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. Sonalleve(R) has also been approved by the China Food and Drug Administration for the non-invasive treatment of uterine fibroids. The Company is in the early stages of exploring additional potential treatment markets for Sonalleve(R) where the technology has been shown to have clinical application, such as non-invasive ablation of abdominal cancers and hyperthermia for cancer therapy."
I grabbed a bunch today.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PROF News